Estrogens in the nervous system: Mechanisms and nonreproductive functions

Annual Review of Physiology

Volumn 66, Issue , 2004, Pages 291-313

  Maggi, Adriana ^a   Ciana, Paolo ^a   Belcredito, Silvia ^a   Vegeto, Elisabetta ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Aging; Brain; Estradiol; Neuroprotection; Transcription mechanism

Indexed keywords

CYTOKINE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; STEROID RECEPTOR;

CELL DIVISION; CENTRAL NERVOUS SYSTEM FUNCTION; CYTOPLASM; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; NERVE CELL; NERVE DEGENERATION; NERVE POTENTIAL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; RECEPTOR BINDING; REPRODUCTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BRAIN; CELL PROTECTION; CYTOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; CYTOPROTECTION; ESTRADIOL; ESTROGENS; HUMANS; NEURONS;

EID: 2342582858     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.66.032802.154945     Document Type: Review

References (156)

1. Gorski RA. 1971. Gonadal hormones and the perinatal development of neuroendocrine function. In Frontiers in Neuroendocrinology, ed. L Martini, WF Ganong, pp. 237-290. New York: Oxford Univ. Press
2. Arai Y. 2000. Sexual differentiation of the brain: a historical review. In Sexual Differentiation of the Brain, ed. A Matsumoto, pp. 1-9. Boca Raton: CRC Press
3. McEwen BS. 1981. Neural gonadal steroid actions. Science 211(4488):1303-11
4. Green S, Walter P, Kumar V, Krust A, Bornert JM, et al. 1986. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320(6058):134-39
5. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. 1996. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 93(12):5925-30
6. 5a. Nuclear Receptor Nomenclature Committee. 1999. A unified nomenclature system for the nuclear receptor superfamily. Cell 97:161-63
7. Ciana P, Vegeto E, Beato M, Chambon P, Gustaffsson J-Å, et al. 2002. Looking at nuclear receptors from the heights of Erice. EMBO Rep. 3(2):125-29
8. Levin ER. 2001. Cell localization, physiology, and non-genomic actions of estrogen receptors. J. Appl. Physiol. 91:1860-67
9. Razandi M, Pedram A, Greene GL, Levin ER. 1999. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells. Mol. Endocrinol. 13(2):307-19
10. Pietras RJ, Szego CM. 1977. Specific binding sites for oestrogen at the outer surface of isolated endometrial cells. Nature 265(5589): 69-72
11. Pappas TC, Gametchu B, Watson CS. 1995. Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J. 9(5):404-10
12. Toran-Allerand CD, Guan X, MacLusky NJ, Horvath TL, Diano S, et al. 2002. ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J. Neurosci. 22(19):8391-401
13. Price RH Jr, Lorenzon N, Handa RJ. 2000. Differential expression of estrogen receptor beta splice variants in rat brain: identification and characterization of a novel variant missing exon 4. Brain Res. Mol. Brain Res. 80:260-68
14. Shupnik MA. 2002. Oestrogen receptors, receptor variants and oestrogen actions in the hypothalamic-pituitary axis. J. Neuroendocrinol. 14(2):85-94
15. Bolling A, Miksicek RJ. 2000. An estrogen-receptor-alpha splicing variant mediates both positive and negative effects on gene transcription. Mol. Endocrinol. 14:634-49
16. Ma ZQ, Spreafico E, Pollio G, Santagati S, Conti E, et al. 1993. Activated estrogen receptor mediates growth arrest and differentiation of a neuroblastoma cell line. Proc. Natl. Acad. Sci. USA 90(8):3740-44
17. Lustig RH, Hua P, Yu W, Ahmad FJ, Baas PW. 1994. An in vitro model for the effects of estrogen on neurons employing estrogen receptor-transfected PC12 cells. J. Neurosci. 14(6):3945-57
18. Fitzpatrick JL, Mize AL, Wade CB, Harris JA, Shapiro RA, Dorsa DM. 2002. Estrogen-mediated neuroprotection against beta-amyloid toxicity requires expression of estrogen receptor alpha or beta and activation of the MAPK pathway. J. Neurochem. 82(3):674-82
19. Garnier M, Di Lorenzo D, Albertini A, Maggi A. 1997. Identification of estrogen-responsive genes in neuroblastoma SK-ER3 cells. J. Neurosci. 17(12):4591-99
20. Vegeto E, Pollio G, Pellicciari C, Maggi A. 1999. Estrogen and progesterone induction of survival of monoblastoid cells undergoing TNF-alpha-induced apoptosis. FASEB J. 13(8):793-803
21. Meda C, Vegeto E, Pollio G, Ciana P, Patrone C, et al. 2000. Oestrogen prevention of neural cell death correlates with decreased expression of mRNA for the pro-apoptotic protein nip-2. J. Neuroendocrinol. 12(11):1051-59
22. Brusadelli A, Sialino H, Piepoli T, Pollio G, Maggi A. 2000. Expression of the estrogen-regulated gene Nip2 during rat brain maturation. Int. J. Dev. Neurosci. 18(2-3):317-20
23. Ciana P, Ghisletti S, Mussi P, Eberini I, Vegeto E, Maggi A. 2003. ERalpha, a molecular switch converting TGFalpha-mediated proliferation into differentiation in neuroblastoma cells . J. Biol. Chem. In press
24. Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, et al. 1997. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 277(5331):1508-10
25. McKay LI, Cidlowski JA. 1999. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr. Rev. 20(4):435-59
26. Pfeilschifter J, Koditz R, Pfohl M, Schatz H. 2002. Changes in proinflammatory cytokine activity after menopause. Endocr. Rev. 2002. 23(1):90-119
27. Stein B, Yang MX. 1995. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol. Cell. Biol. 15(9):4971-79
28. Galien R, Garcia T. 1997. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB. Nucleic Acids Res. 25(12):2424-29
29. An J, Ribeiro RC, Webb P, Gustafsson JA, Kushner PJ, et al. 1999. Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators. Proc. Natl. Acad. Sci. USA 96(26):15161-66
30. Tzagarakis-Foster C, Geleziunas R, Lomri A, An J, Leitman DC. 2002. Estradiol represses human T-cell leukemia virus type 1 Tax activation of tumor necrosis factor-alpha gene transcription. J. Biol. Chem. 277(47):44772-77
31. Vegeto E, Bonincontro C, Pollio G, Sala A, Viappiani S, et al. 2001. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J. Neurosci. 21(6):1809-18
32. Kelly MJ, Moss RL, Dudley CA. 1976. Differential sensitivity of preoptic-septal neurons to microelectrophoresed estrogen during the estrous cycle. Brain Res. 114(1):152-57
33. Mermelstein PG, Becker JB, Surmeier DJ. 1996. Estradiol reduces calcium currents in rat neostriatal neurons via membrane receptors. J. Neurosci. 16:595-604
34. Wetzel CH, Hermann B, Behl C, Pestel E, Rammes G, et al. 1998. Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor. Mol. Endocrinol. 12(9):1441-51
35. Valverde MA, Rojas P, Amigo J, Cosmelli D, Orio P, et al. 1999. Acute activation of Maxi-K channels (hSlo) by estradiol binding to the beta subunit. Science 285(5435):1929-31
36. Gu Q, Moss RL. 1996. 17beta estradiol potentiates kainate-induced currents via activation of the cAMP cascade. J. Neurosci. 16:3620-29
37. Minami T, Oomura Y, Nabekura J, Fukuda A. 1990. 17beta-estradiol depolarization of hypothalamic neurons is mediated by cAMP. Brain Res. 519:301-7
38. Aronica SM, Kraus WL, Katzenellenbogen BS. 1994. Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc. Natl. Acad. Sci. USA 91(18):8517-21
39. Watters JJ, Dorsa DM. 1998. Transcriptional effects of estrogen on neuronal neurotensin gene expression involve cAMP/ protein kinase A-dependent signaling mechanisms. J. Neurosci. 18(17):6672-80
40. Kelly MJ, Levin ER. 2001. Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol. Metab. 12(4):152-56
41. Maus M, Bertrand P, Drouva S, Rasolonjanahary R, Kordon C, et al. 1989. Differential modulation of D1 and D2 dopamine-sensitive adenylate cyclases by 17 beta-estradiol in cultured striatal neurons and anterior pituitary cells. J. Neurochem. 52(2):410-18
42. Russell KS, Haynes MP, Sinha D, Clerisme E, Bender JR. 2000. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc. Natl. Acad. Sci. USA 97(11):5930-35
43. Palmon SC, Williams MJ, Littleton-Kearney MT, Traystman RJ, Kosk-Kosicka D, Hurn PD. 1998. Estrogen increases cGMP in selected brain regions and in cerebral microvessels. J. Cereb. Blood Flow Metab. 18(11):1248-52
44. Le Mellay V, Grosse B, Lieberherr M. 1997. Phospholipase C beta and membrane action of calcitriol and estradiol. J. Biol. Chem. 272(18):11902-7
45. Lagrange AH, Ronnekleiv OK, Kelly MJ. 1997. Modulation of G protein-coupled receptors by an estrogen receptor that activates protein kinase A. Mol. Pharmacol. 51(4):605-12
46. Coleman KM, Dutertre M, El-Gharbawy A, Rowan BG, Weigel NL, Smith CL. 2003. Mechanistic differences in the activation of estrogen receptor-alpha (ERalpha)- and ERbeta-dependent gene expression by cAMP signaling pathway(s). J. Biol. Chem. 278(15):12834-45
47. Colin IM, Jameson JL. 1998. Estradiol sensitization of rat pituitary cells to gonadotropin-releasing hormone: involvement of protein kinase C- and calcium-dependent signaling pathways. Endocrinology 139(9):3796-802
48. Ansonoff MA, Etgen AM. 1998. Estradiol elevates protein kinase C catalytic activity in the preoptic area of female rats. Endocrinology 139(7):3050-56
49. Zhang L, Rubinow DR, Xaing G, Li BS, Chang YH, et al. 2001. Estrogen protects against beta-amyloid-induced neurotoxicity in rat hippocampal neurons by activation of Akt. NeuroReport 12(9):1919-23
50. Znamensky V, Akama KT, McEwen BS, Milner TA. 2003. Estrogen levels regulate the subcellular distribution of phosphorylated Akt in hippocampal CA1 dendrites. J. Neurosci. 23(6):2340-47
51. Hayashi T, Ishikawa T, Yamada K, Kuzuya M, Naito M, et al. 1994. Biphasic effect of estrogen on neuronal constitutive nitric oxide synthase via Ca(2+)-calmodulin dependent mechanism. Biochem. Biophys. Res. Commun. 203(2):1013-19
52. Razandi M, Pedram A, Levin ER. 2000. Estrogen signals to the preservation of endothelial cell form and function. J. Biol. Chem. 275(49):38540-46
53. Wade CB, Robinson S, Shapiro RA, Dorsa DM. 2001. Estrogen receptor (ER)alpha and ERbeta exhibit unique pharmacologic properties when coupled to activation of the mitogen-activated protein kinase pathway. Endocrinology 142(6):2336-42
54. Gu G, Rojo AA, Zee MC, Yu J, Simerly RB. 1996. Hormonal regulation of CREB phosphorylation in the anteroventral periventricular nucleus. J. Neurosci. 16(9):3035-44
55. Honda K, Shimohama S, Sawada H, Kihara T, Nakamizo T, et al. 2001. Nongenomic antiapoptotic signal transduction by estrogen in cultured cortical neurons. J. Neurosci. Res. 64(5):466-75
56. Jezierski MK, Sturm A, Scarborough MM, Sohrabji F. 2000. NGF stimulation increases JNK phosphorylation and reduces caspase-3 activity in the olfactory bulb of estrogen-replaced animals. Endocrinology 142:2401-3
57. Wyckoff MH, Chambliss KL, Mineo C, Yuhanna IS, Mendelsohn ME, et al. 2001. Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase through Galpha(i). J. Biol. Chem. 276(29):27071-76
58. Kelly MJ, Qiu J, Wagner EJ, Ronnekleiv OK. 2003. Rapid effects of estrogen on G protein-coupled receptor activation of potassium channels in the central nervous system (CNS). J. Steroid Biochem. Mol. Biol. 83:187-93
59. Dominguez F, Magdalena C, Cancio E, Roson E, Paredes J, et al. 1993. Tissue concentrations of prothymosin alpha: a novel proliferation index of primary breast cancer. Eur. J. Cancer 29A(6):893-97
60. Altucci L, Addeo R, Cicatiello L, Germano D, Pacilio C, et al. 1997. Estrogen induces early and timed activation of cyclin-dependent kinases 4, 5, and 6 and increases cyclin messenger ribonucleic acid expression in rat uterus. Endocrinology 138(3):978-84
61. Brannvall K, Korhonen L, Lindholm D. 2002. Estrogen-receptor-dependent regulation of neural stem cell proliferation and differentiation. Mol. Cell. Neurosci. 21(3):512-20
62. Björnoström L, Sjöberg M. 2002. Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptors actions. Mol. Endocrinol. 16:2202-14
63. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, et al. 1996. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15(6):1292-300
64. Castoria G, Barone MV, Di Domenico M, Bilancio A, Ametrano D, et al. 1999. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. EMBO J. 18(9):2500-10
65. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK. 2000. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407(6803):538-41
66. Singer CA, Figueroa-Maso XA, Batchelor RH, Dorsa DM. 1999. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J. Neurosci. 19:2455-63
67. Singh M, Setalo G Jr, Guan X, Warren M, Toran-Allerand CD. 1999. Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J. Neurosci. 19(4):1179-88
68. Manthey D, Heck S, Engert S, Behl C. 2001. Estrogen induces a rapid secretion of amyloid beta precursor protein via the mitogen-activated protein kinase pathway. Eur. J. Biochem. 268(15):4283-91
69. Znamensky V, Akama KT, McEwen BS, Milner TA. 2003. Estrogen levels regulate the subcellular distribution of phosphorylated Akt in hippocampal CA1 dendrites. J. Neurosci. 23(6):2340-47
70. Wong CW, McNally C, Nickbarg E, Komm BS, Cheskis BJ. 2002. Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc. Natl. Acad. Sci. USA 99(23):14783-88
71. Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM, Weinberg RA. 1993. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 363(6424):45-51
72. Thornton JW. 2001. Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions. Proc. Natl. Acad. Sci. USA 98(10):5671-76
73. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, et al. 1995. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270(5241):1491-94
74. Ma ZQ, Santagati S, Patrone C, Pollio G, Vegeto E, Maggi A. 1994. Insulin-like growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastoma cell line SK-ER3. Mol. Endocrinol 8:910-18
75. Couse JF, Lindzey J, Grandien K, Gustafsson JA, Korach KS. 1997. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology 138(11):4613-21
76. Shughrue PJ, Merchenthaler I. 2001. Distribution of estrogen receptor beta immunoreactivity in the rat central nervous system. J. Comp. Neurol. 436(1):64-81
77. Jung-Testas I, Renoir M, Bugnard H, Greene GL, Baulieu EE. 1992. Demonstration of steroid hormone receptors and steroid action in primary cultures of rat glial cells. J. Steroid Biochem. Mol. Biol. 41(3-8):621-31
78. Santagati S, Melcangi RC, Celotti F, Martini L, Maggi A. 1994. Estrogen receptor is expressed in different types of glial cells in culture. J. Neurochem. 63(6):2058-64
79. Vegeto E, Belcredito S, Etteri S, Ghisletti S, Brusadelli A, et al. 2003. Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol. Proc. Natl. Acad. Sci. USA. In press
80. Brannvall K, Korhonen L, Lindholm D. 2002. Estrogen-receptor-dependent regulation of neural stem cell proliferation and differentiation. Mol. Cell. Neurosci. 21(3):512-20
81. Tanapat P, Hastings NB, Reeves AJ, Gould E. 1999. Estrogen stimulates a transient increase in the number of new neurons in the dentate gyrus of the adult female rat. J. Neurosci. 19(14):5792-801
82. Maggi A, Susanna L, Bettini E, Mantero G, Zucchi I. 1989. Hippocampus: a target for estrogen action in mammalian brain. Mol. Endocrinol. 3(7):1165-70
83. Fugger HN, Cunningham SG, Rissman EF, Foster TC. 1998. Sex differences in the activational effect of ERalpha on spatial learning. Horm. Behav. 34(2):163-70
84. Luine V, Rodriguez M. 1994. Effects of estradiol on radial arm maze performance of young and aged rats. Behav. Neural. Biol. 62(3):230-36
85. Singh M, Meyer EM, Millard WJ, Simpkins JW. 1994. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res. 644(2):305-12
86. Frick KM, Fernandez SM, Bulinski SC. 2002. Estrogen replacement improves spatial reference memory and increases hippocampal synaptophysin in aged female mice. Neuroscience 115(2):547-58
87. Lund TD, West TW, Tian LY, Bu LH, Simmons DL, et al. 2001. Visual spatial memory is enhanced in female rats (but inhibited in males) by dietary soy phytoestrogens. BMC Neurosci. 2(1):20
88. Sandstrom NJ, Williams CL. 2001. Memory retention is modulated by acute estradiol and progesterone replacement. Behav. Neurosci. 115(2):384-93
89. Markham JA, Pych JC, Juraska JM. 2002. Ovarian hormone replacement to aged ovariectomized female rats benefits acquisition of the Morris water maze. Horm. Behav. 42(3):284-93
90. Packard MG, Teather LA. 1997. Intrahippocampal estradiol infusion enhances memory in ovariectomized rats. NeuroReport 8(14):3009-13
91. Galea LA, Kavaliers M, Ossenkopp KP, Hampson E. 1995. Gonadal hormone levels and spatial learning performance in the Morris water maze in male and female meadow voles, Microtus pennsylvanicus. Horm. Behav. 29(1):106-25
92. Fader AJ, Hendricson AW, Dohanich GP. 1998. Estrogen improves performance of reinforced T-maze alternation and prevents the amnestic effects of scopolamine administered systemically or intrahippocampally. Neurobiol. Learn Mem. 69(3):225-40
93. Bimonte HA, Denenberg VH. 1999. Estradiol facilitates performance as working memory load increases. Psychoneuroendocrinology 24(2):161-73
94. Gibbs RB. 1999. Estrogen replacement enhances acquisition of a spatial memory task and reduces deficits associated with hippocampal muscarinic receptor inhibition. Horm. Behav. 36(3):222-33
95. Foy MR, Teyler TJ. 1983. 17-alpha-estradiol and 17-beta-estradiol in hippocampus. Brain Res. Bull. 10(6):735-39
96. Woolley CS, Gould E, Frankfurt M, McEwen BS. 1990. Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons. J. Neurosci. 10(12):4035-39
97. Rissman EF, Heck AL, Leonard JE, Shupnik MA, Gustafsson JA. 2002. Disruption of estrogen receptor beta gene impairs spatial learning in female mice. Proc. Natl. Acad. Sci. USA 99(6):3996-4001
98. Ogawa S, Lubahn DB, Korach KS, Pfaff DW. 1997. Behavioral effects of estrogen receptor gene disruption in male mice. Proc. Natl. Acad. Sci. USA 94(4):1476-81
99. Geary N, Asarian L, Korach KS, Pfaff DW, Ogawa S. 2001. Deficits in E2-dependent control of feeding, weight gain, and cholecystokinin satiation in ER-alpha null mice. Endocrinology 142(11):4751-57
100. Nomura M, Durbak L, Chan J, Smithies O, Gustafsson JA, et al. 2002. Genotype/age interactions on aggressive behavior in gonadally intact estrogen receptor beta knockout (betaERKO) male mice. Horm. Behav. 41(3):288-96
101. Behl C, Skutella T, Lezoualc'h F, Post A, Widmann M, et al. 1997. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol. Pharmacol. 51(4):535-41
102. Goodman Y, Bruce AJ, Cheng B, Mattson MP. 1996. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons. J. Neurochem. 66(5):1836-44
103. Gridley KE, Green PS, Simpkins JW. 1997. Low concentrations of estradiol reduce beta-amyloid (25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells. Brain Res. 778(1):158-65
104. Wang Q, Santizo R, Baughman VL, Pelligrino DA, Iadecola C. 1999. Estrogen provides neuroprotection in transient forebrain ischemia through perfusion-independent mechanisms in rats. Stroke 30(3):630-37
105. Dubal DB, Zhu H, Yu J, Rau SW, Shughrue PJ, et al. 2001. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc. Natl. Acad. Sci. USA 98(4):1952-57
106. Weaver CE Jr, Park-Chung M, Gibbs TT, Farb DH. 1997. 17beta-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res. 761(2):338-41
107. Bebo BF Jr, Fyfe-Johnson A, Adlard K, Beam AG, Vandenbark AA, Offner H. 2001. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J. Immunol. 166(3):2080-89
108. Weissman MM, Bland R, Joyce RP, Newman S, Wells JE, Wittchen HU. 1993. Sex differences in rates of depression: cross-national perspectives. J. Affect. Disord. 29(2-3):77-84
109. Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow RD. 2000. Effects of gonadal steroids in women with a history of postpartum depression. Am. J. Psych. 157(6):924-30
110. Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW. 1996. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 347(9006):930-33
111. Jansson L, Holmdahl R. 1998. Estrogen-mediated immunosuppression in autoimmune diseases. Inflamm. Res. 47(7):290-301
112. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. 1998. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N. Engl. J. Med. 339(5):285-91
113. Henderson VW. 1997. The epidemiology of estrogen replacement therapy and Alzheimer's disease. Neurology 48(5 Suppl. 7):S27-35
114. Yaffe K, Sawaya G, Lieberburg I, Grady D. 1998. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 279(9):688-95
115. Tsang KL, Ho SL, Lo SK. 2000. Estrogen improves motor disability in Parkinsonian postmenopausal women with motor fluctuations. Neurology 54(12):2292-98
116. Huber TJ, Rollnik J, Wilhelms J, von zur Muhlen A, Emrich HM, Schneider U. 2001. Estradiol levels in psychotic disorders. Psychoneuroendocrinology 26(1):27-35.
117. Paganini-Hill A. 1995. Estrogen replacement therapy and stroke. Prog. Cardiovasc. Dis. 38(3):223-42
118. Jarvik LF. 1975. Human intelligence: sex differences. Acta Genet. Med. Gamellol. 24(3-4):189-211
119. Kampen DL, Sherwin BB. 1994. Estrogen use and verbal memory in healthy post-menopausal women. Obstet. Gynecol. 83(6):979-83
120. Sherwin BB. 1997. Estrogen effects on cognition in menopausal women. Neurology 48(5 Suppl. 7):S21-26
121. Robinson D, Friedman L, Marcus R, Tinklenberg J, Yesavage J. 1994. Estrogen replacement therapy and memory in older women. J. Am. Geriatr. Soc. 42(9):919-22
122. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, et al. 1997. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 48(6):1517-21
123. Carswell HV, Dominiczak AF, Macrae IM. 2000. Estrogen status affects sensitivity to focal cerebral ischemia in stroke-prone spontaneously hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 278(1):H290-94
124. Veliskova J, Velisek L, Galanopoulou AS, Sperber EF. 2000. Neuroprotective effects of estrogens on hippocampal cells in adult female rats after status epilepticus. Epilepsia 41(Suppl. 6):S30-35
125. Liu HY, Buenafe AC, Matejuk A, Ito A, Zamora A, et al. 2002. Estrogen inhibition of EAE involves effects on dendritic cell function. J. Neurosci. Res. 70(2):238-48
126. Ito A, Bebo BF Jr, Matejuk A, Zamora A, Silverman M, et al. 2001. Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J. Immunol. 167(1):542-52
127. 3H]estradiol related to steroid responsiveness in cultures of the newborn mouse hypothalamus and preoptic area. Brain Res. 184:517-22
128. Blanco G, Diaz H, Carrer HF, Beauge L. 1990. Differentiation of rat hippocampal neurons induced by estrogen in vitro: effects on neuritogenesis and Na, K-ATPase activity. J. Neurosci. Res. 27(1):47-54
129. Brinton RD, Tran J, Proffitt P, Montoya M. 1997. 17 beta-Estradiol enhances the outgrowth and survival of neocortical neurons in culture. Neurochem. Res. 22(11):1339-51
130. Murphy DD, Cole NB, Greenberger V, Segal M. 1998. Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. J. Neurosci. 18(7):2550-59
131. Perez-Polo JR, Hall K, Livingston K, Westlund K. 1977. Steroid induction of nerve growth factor synthesis in cell culture. Life Sci. 21(10):1535-44
132. Sohrabji F, Miranda RC, Toran-Allerand CD. 1994. Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons. J. Neurosci. 14(2):459-71
133. Lara HE, McDonald JK, Ojeda SR. 1990. Involvement of nerve growth factor in female sexual development. Endocrinology 126(1):364-75
134. Agrati P, Garnier M, Patrone C, Pollio G, Santagati S, et al. 1997. SK-ER3 neuroblastoma cells as a model for the study of estrogen influence on neural cells. Brain Res. Bull. 44(4):519-23
135. Sohrabji F, Miranda RC, Toran-Allerand CD. 1995. Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. USA 92(24):11110-14
136. Cardona-Gomez GP, Chowen JA, Garcia-Segura LM. 2000. Estradiol and progesterone regulate the expression of insulin-like growth factor-I receptor and insulin-like growth factor binding protein-2 in the hypothalamus of adult female rats. J. Neurobiol. 43(3):269-81
137. Kawaja MD, Gage FH. 1991. Reactive astrocytes are substrates for the growth of adult CNS axons in the presence of elevated levels of nerve growth factor. Neuron 7(6):1019-30
138. Patrone C, Pollio G, Vegeto E, Enmark E, de Curds I, et al. 2000. Estradiol induces differential neuronal phenotypes by activating estrogen receptor alpha or beta. Endocrinology 141(5):1839-45
139. Behl C, Widmann M, Trapp T, Holsboer F. 1995. 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216:473-82
140. Regan RF, Guo Y. 1997. Estrogens attenuate neuronal injury due to hemoglobin, chemical hypoxia and excitatory amino acids in murine cortical cultures. Brain Res. 764:133-40
141. Gollapudi L, Oblinger MM. 1999. Stable transfection of PC12 cells with estrogen receptor (ERalpha): protective effects of estrogen on cell survival after serum deprivation. J. Neurosci. Res. 56(1):99-108
142. Patrone C, Andersson S, Korhonen L, Lindholm D. 1999. Estrogen receptor-dependent regulation of sensory neuron survival in developing dorsal root ganglion. Proc. Natl. Acad. Sci. USA. 96(19):10905-10
143. Pike CJ. 1999. Estrogen modulates neuronal Bcl-Xl expression and β-amyloid-induced apoptosis: relevance to Alzheimer's disease. J. Neurochem. 72(4):1552-63
144. McGeer PL, McGeer EG. 1996. Antiinflammatory drugs in the fight against Alzheimer's disease. Ann. NY Acad. Sci. 777:213-20
145. Santizo RA, Anderson S, Ye S, Koenig HM, Pelligrino DA. 2000. Effects of estrogen on leukocyte adhesion after transient forebrain ischemia. Stroke 31(9):2231-35
146. Matsuda J, Vanier MT, Saito Y, Suzuki K, Suzuki K. 2001. Dramatic phenotypic improvement during pregnancy in a genetic leukodystrophy: estrogen appears to be a critical factor. Hum. Mol. Genet. 10(23):2709-15
147. Matejuk A, Adlard K, Zamora A, Silverman M, Vandenbark AA, Offner H. 2001. 17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis. J. Neurosci. Res. 65(6):529-42
148. Horsburgh K, Macrae IM, Carswell H. 2002. Estrogen is neuroprotective via an apolipoprotein E-dependent mechanism in a mouse model of global ischemia. J. Cereb. Blood Flow Metab. 22(10):1189-95
149. Gonzalez-Scarano F, Baltuch G. 1999. Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 22:219-40
150. Kalaria RN. 1999. Microglia and Alzheimer's disease. Curr. Opin. Hematol. 6(1):15-24
151. Bruce-Keller AJ, Keeling JL, Keller JN, Huang FF, Camondola S, Mattson MP. 2000. Antiinflammatory effects of estrogen on microglial activation. Endocrinology 141(10):3646-56
152. Li R, Shen Y, Yang LB, Lue LF, Finch C, Rogers J. 2000. Estrogen enhances up-take of amyloid beta-protein by microglia derived from the human cortex. J. Neurochem. 75(4):1447-54
153. Gilmore W, Weiner LP, Correale J. 1997. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J. Immunol. 158(1):446-51
154. Correale J, Arias M, Gilmore W. 1998. Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects. J. Immunol. 161(7):3365-74
155. Nathan L, Pervin S, Singh R, Rosenfeld M, Chaudhuri G. 1999. Estradiol inhibits leukocyte adhesion and transendothelial migration in rabbits in vivo: possible mechanisms for gender differences in atherosclerosis. Circ. Res. 85(4):377-85
156. Caulin-Glaser T, Farrell WJ, Pfau SE, Zaret B, Bunger K, et al. 1998. Modulation of circulating cellular adhesion molecules in postmenopausal women with coronary artery disease. J. Am. Coll. Cardiol. 31(7):1555-60